Masatake Kobayashi
Masatake Kobayashi, MD, PhD is an expert in Cardiology at Tokyo Medical University Hospital (Japan). Masatake Kobayashi has authored 81 publications, the most recent in 2025, and is an investigator in 5 clinical trials, 1 of them ongoing. SLR score: 285 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Nephrology - Genetics - Transplantation
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2018 - 2026
Number : 81
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction. PMID 40955522 — heart failure, heart, receptors, mineralocorticoid, heart failure, systolic, therapeutics, mineralocorticoids, mineralocorticoid receptor antagonists | Eur J Heart Fail | 2025 | 3 |
| Interaction Between Aldosterone and Mineralocorticoid Receptor Antagonist: Findings From the EPHESUS Trial. PMID 40602178 — aldosterone, serum, myocardial infarction, heart failure, receptors, mineralocorticoid, eplerenone, mineralocorticoids, mineralocorticoid receptor antagonists, prognosis | JACC Heart Fail | 2025 | 3 |
| Kidney function trajectories before and after hospitalization for heart failure with reduced ejection fraction. PMID 40737218 — hospitalization, heart failure, heart, kidney, cardiology, heart failure, systolic | Eur Heart J Top journal | 2025 | 0 |
| Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease. PMID 40214750 — kidney diseases, hypertension, aldosterone, kidney, cardiology, therapeutics | Eur Heart J Top journal | 2025 | 1 |
| Trajectory, correlates, and outcomes of pulmonary congestion by lung ultrasound in patients hospitalized for acute pulmonary edema. PMID 40623632 — pulmonary edema, lung, hospitalization, cardiology, edema, prognosis | Int J Cardiol | 2025 | 8 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Early Treatment With a Sodium glucose Co transporter 2 Inhibitor in High risk Patients With Acute Heart Failure NCT05392764 — heart failure, heart, symporters, therapeutics | Phase 3 | Recruiting | 2022 |
LeadR Networks
Main global connection map